Canagliflozin-Induced Adaptive Metabolism in Bone. [PDF]
Poudel SB +14 more
europepmc +1 more source
Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways. [PDF]
Fayed HM +9 more
europepmc +1 more source
Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B. [PDF]
Zhang J +5 more
europepmc +1 more source
Canagliflozin potentially promotes renal protection against glycerol-induced acute kidney injury by activating the AMPK/SIRT1/FOXO-3a/PGC-1α and Nrf2/HO-1 pathways. [PDF]
Bishr A +3 more
europepmc +1 more source
Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells. [PDF]
Yang Y +11 more
europepmc +1 more source
Sodium-glucose cotransporter 2 inhibitors facilitate cell phenotype conversion of alpha cells through progenitors to beta cells by activating Ppargc1α in diabetic mice. [PDF]
Jiang Y +8 more
europepmc +1 more source
Canagliflozin ameliorates high-salt-induced renal injury and premature aging in male Dahl salt-sensitive rats, with associated changes in SIRT6/HIF-1α signaling. [PDF]
Wang Q +11 more
europepmc +1 more source
<i>Dimerocostus strobilaceus</i> (Caña Agria) as an Emerging Reservoir of Bioactive Metabolites with Potential Antioxidant, Antimicrobial, Anticancer and Anti-Inflammatory Health Benefits. [PDF]
Coyago-Cruz E +7 more
europepmc +1 more source
Discrimination of normal from slow-aging mice by plasma metabolomic and proteomic features. [PDF]
Badenoch B +6 more
europepmc +1 more source

